From Policy to Patients:
A Legacy of Care
Since its founding in 1999, the Indian Pharmaceutical Alliance (IPA) has been at the forefront of India’s transformation into a global pharmaceutical leader — bridging policy and patient care through advocacy, innovation, and an unwavering commitment to quality and access. Representing 23 of the country’s top research-based pharmaceutical companies, IPA continues to play a key role in shaping national and global pharmaceutical policy with one guiding principle: putting patients first.
Our Mission
Innovation
that transforms healthcare
Driving an innovation-led research ecosystem to position India as a global leader in life sciences with interdisciplinary collaboration, scientific breakthroughs, and policies that enable long-term, sustainable innovation.
Inside the Lab
Quality
that builds trust
Commitment to drive excellence in pharmaceutical quality by building capabilities, benchmarking against global standards, and promoting the sharing of best practices across the industry.
Our Quality Standards
Global Reach
that expands access
Expanding global footprint of Indian companies to enhance the affordability, availability, and accessibility of quality medicines worldwide.
Track the ImpactInsights
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India’s pharmaceutical sector has become the world’s largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
Blog 12 May 2025 • 5 min read
India’s Green Manufacturing Odyssey: A New Era for Pharma
Indian pharma isn’t just advancing health — it’s reimagining responsibility. From green manufacturing practices to sustainable sourcing and energy efficiency, IPA members are embedding environmental stewardship into....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
News July 14, 2025
Patents: Navigating innovation and access in India
The Hindu Business Line
Read More ›
News July 3, 2025
COVID vaccines not tied to sudden deaths: Experts refute Karnataka CM’s claims
CNBC TV 18
Read More ›
News June 24, 2025
FTAs are welcome but don’t let them undermine pharma industry and drug access by Archana Jatkar
Money Control
Read More ›
External Study July 1, 2025 • 8 min read
Frost & Sullivan : Driving an Innovative Biologics Pipeline in India
Read More ›
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India’s pharmaceutical sector has become the world’s largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
Article July 22, 2025 • 4 min read
Sustainability: The New Pillar of Indian Pharma by Sudarshan Jain
Read More ›
Article May 19, 2025 • 4 min read
Space: Pharma’s Next Frontier?
Space, once the exclusive domain of astronauts, space stations, and satellites, is emerging as a critical enabler of pharmaceutical and biomedical innovation.
Read More ›
Article January 27, 2025 • 4 min read
Indo-US Pharma Alliance: Time to Step Up
In today’s VUCA world, national security extends to health security, with affordable medicines being vital for both India and the U.S
Read More ›
Reports February 1, 2025
Best Practices for Authentication Track Trace in Pharmaceutical Products Packaging
View Publication ›
Spotlight
Podcast: The Future of Indian Pharma
In this special panel hosted by the Economic Times, three leading voices from the Indian pharmaceutical industry — Dr. Sharvil Patel (Vice President, IPA and Managing Director, Zydus Lifesciences), Aman Mehta (Managing Director, Torrent Pharmaceuticals), and Namita Thapar (Executive Director, Emcure Pharmaceuticals) — come together to reflect on India’s evolving role in global health.
The conversation explores how the sector is shifting its focus from being the world’s pharmacy for generics to a future led by innovation. The leaders discuss what it will take to achieve this, including regulatory reforms, public-private partnerships, and greater investment in R&D and discovery research.
Tune in as they join Vikas Dandekar, Editor, Pharma & Healthcare, on The Economic Times’ podcast #CornerOfficeConversation.
Watch NowPharmacy of the World
#1
Global leader in generic medicines
3rd
Largest pharma industry in the world by volume
5th
Largest net exporter of medicines in the world
$58B
Annual output of the Indian pharmaceutical industry
750+
FDA registered generic manufacturing sites – Highest globally
11th
Largest pharma industry in the world by value
2x
Export orientation compared to overall manufacturing sector
$30B
Value of Indian pharmaceutical exports in FY25
In Focus
25 Years of Policy, Partnership, and Progress
The Indian Pharmaceutical Alliance (IPA) was established by leading Indian pharmaceutical companies to serve as a unified voice for the industry.
1999
IPA helps shape India’s TRIPS position at the WTO, safeguarding public health priorities.
2003
IPA leads engagement on India’s patent law amendments during the shift to a product patent regime.
2005
IPA gains global recognition in policy and regulatory forums on IP, generics, and pricing.
2010
Led by IPA, a dedicated Quality Forum was established with the purpose of establishing the Indian pharma industry as a benchmark for quality and global excellence
2015
Partners with government on Make in India, API self-reliance, and affordability strategies.
2019
Plays a central role during COVID-19 — enabling vaccine access, ensuring medicine supply, and supporting emergency policy response.
2020
Hosts the first Global Innovation Summit with 3000+ attendees, outlining key imperatives to strengthen India’s life sciences innovation ecosystem.
2021
IPA members lead global biosimilar exports, marking India's innovation-driven growth.
2024
IPA marks 25 years — championing policy, access, innovation, and global healthcare leadership.